Skip to main content
SpringerLink
Log in

Routine meningococcal B vax could be justified in England

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Christensen H, et al. Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study. BMJ 349: g5725, 9 Oct 2014. Available from: URL: http://dx.doi.org/10.1136/bmj.g5725

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Routine meningococcal B vax could be justified in England. PharmacoEcon Outcomes News 714, 24 (2014). https://doi.org/10.1007/s40274-014-1645-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1645-x

Search

Navigation